以聚乳酸/羟基乙酸(PLGA)共聚物为药物装载材料、油酸改性的四氧化三铁(Fe 3 O 4@OA)纳米颗粒为磁性功能材料,制备姜黄素/PLGA磁性微球,考察了乳化方法、高速均质速度、水油相体积比、PLGA用量、水相聚乙烯醇(PVA)质量分数、Fe 3 O 4@O...以聚乳酸/羟基乙酸(PLGA)共聚物为药物装载材料、油酸改性的四氧化三铁(Fe 3 O 4@OA)纳米颗粒为磁性功能材料,制备姜黄素/PLGA磁性微球,考察了乳化方法、高速均质速度、水油相体积比、PLGA用量、水相聚乙烯醇(PVA)质量分数、Fe 3 O 4@OA用量和姜黄素用量对磁性微球粒径的影响,并通过光学显微镜、激光粒度仪、紫外分光光度计、振动样品磁强计、热重分析仪等对其形貌及理化性能进行分析。研究结果显示:姜黄素/PLGA磁性微球的最佳制备工艺为选用搅拌-均质两步乳化法、高速均质15000 r/min、水油相体积比10∶1、PLGA用量100 mg、水相PVA质量分数1%、Fe 3 O 4@OA用量40 mg和姜黄素用量40 mg,此条件下制备的微球表面光滑,粒径较均一,多分散性指数(PDI)为0.38,平均粒径为3.60μm,微球的磁感应强度为14.12(A·m^(2))/kg,含磁量约为27.98%。载药微球的包封率为97.09%,载药率为6.40%,在体外释放实验中表现出明显的缓释效果。展开更多
Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion sol...Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release.展开更多
文摘以聚乳酸/羟基乙酸(PLGA)共聚物为药物装载材料、油酸改性的四氧化三铁(Fe 3 O 4@OA)纳米颗粒为磁性功能材料,制备姜黄素/PLGA磁性微球,考察了乳化方法、高速均质速度、水油相体积比、PLGA用量、水相聚乙烯醇(PVA)质量分数、Fe 3 O 4@OA用量和姜黄素用量对磁性微球粒径的影响,并通过光学显微镜、激光粒度仪、紫外分光光度计、振动样品磁强计、热重分析仪等对其形貌及理化性能进行分析。研究结果显示:姜黄素/PLGA磁性微球的最佳制备工艺为选用搅拌-均质两步乳化法、高速均质15000 r/min、水油相体积比10∶1、PLGA用量100 mg、水相PVA质量分数1%、Fe 3 O 4@OA用量40 mg和姜黄素用量40 mg,此条件下制备的微球表面光滑,粒径较均一,多分散性指数(PDI)为0.38,平均粒径为3.60μm,微球的磁感应强度为14.12(A·m^(2))/kg,含磁量约为27.98%。载药微球的包封率为97.09%,载药率为6.40%,在体外释放实验中表现出明显的缓释效果。
文摘Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release.